Imunon Inc (IMNN)
1.40
0.00 (0.00%)
USD |
NASDAQ |
May 17, 16:00
1.41
+0.01
(+0.71%)
After-Hours: 20:00
Imunon Revenue (Annual)
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2022 | 0.50M |
| December 31, 2021 | 0.50M |
| December 31, 2020 | 0.50M |
| December 31, 2019 | 0.50M |
| December 31, 2018 | 0.50M |
| December 31, 2017 | 0.50M |
| December 31, 2016 | 0.50M |
| December 31, 2015 | 0.50M |
| December 31, 2014 | 0.50M |
| December 31, 2013 | 0.50M |
| December 31, 2012 | |
| December 31, 2011 | 2.00M |
| December 31, 2010 | |
| December 31, 2009 |
| Date | Value |
|---|---|
| December 31, 2008 | 2.50M |
| December 31, 2007 | |
| December 31, 2006 | 11.25M |
| December 31, 2005 | 12.32M |
| December 31, 2004 | 2.506M |
| September 30, 2003 | |
| September 30, 2002 | |
| September 30, 2001 | |
| September 30, 2000 | 0.0034M |
| September 30, 1999 | 0.00 |
| September 30, 1998 | 0.1742M |
| September 30, 1997 | 0.1213M |
| September 30, 1996 | 0.074M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
0.50M
Minimum
2019
0.50M
Maximum
2019
0.50M
Average
0.50M
Median
2019
Revenue (Annual) Benchmarks
| Avalo Therapeutics Inc | 1.924M |
| iBio Inc | -- |
| Ocugen Inc | 6.036M |
| Petros Pharmaceuticals Inc | 5.822M |
| Moderna Inc | 6.754B |